Back to search
Atypical Ductal Breast Hyperplasia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atypical Ductal Breast Hyperplasia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Atypical Ductal Breast Hyperplasia trials you may qualify forThis phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Inc…
This phase II trial evaluates tamoxifen, with or without omega-3 fatty acids, for reducing risk of breast cancer among postmenopausal and overweight or obese wo…
This phase IIA trial compares the effect of acolbifene versus low dose tamoxifen in preventing breast cancer in premenopausal women at high risk for developing…
The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as wel…
This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify…
This study evaluates whether adding a polygenic risk score evaluation to standard breast cancer risk assessment tools helps African American and Hispanic women…
This randomized phase III trial studies metformin hydrochloride to see how well it works compared to placebo in preventing breast cancer in patients with atypic…